More About Me

Naomi Ko, MD, MPH, is a medical oncologist at Boston Medical Center (BMC) specializing in the treatment of breast cancer. She is also an Associate Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Ko has had a lifelong interest in social justice and health equity, and earned her MD/MPH at Johns Hopkins School of Medicine and School of Health, where she studied health outcomes in vulnerable populations. At BMC, she strives to understand the driving factors behind real-world gaps in applying the latest evidence-based cancer care to treating vulnerable and minority women with breast cancer, and is studying connections between tumor biology, poverty, communications, and treatment regimens as they relate to breast cancer outcomes in different racial and ethnic breast cancer populations. As a care provider, she focuses her recommendations and treatment on the specific needs of each unique patient, considering each patient’s “whole person” and striving to make every patient feel seen and heard.
  • Administrative Title

    Associate Professor, Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine. Member, Boston University Center of Excellence in Women’s Health, Member, Boston University Evans Center for Interdisciplinary Biomedical Research.
  • Residency

    Internal Medicine, Brigham and Womens Hospital
  • Fellowship

    Hematology/oncology, Boston Medical Center
  • Board Certifications

    Internal Medicine and Medical Oncology, American Board of Internal Medicine
  • Special Interests

    Breast cancer, cancer disparities, health equity
  • Languages

    Mandarin Chinese


Boston University

Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.

See my Boston University profile

Featured on HealthCity

HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.